| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |